OUR TEAM

Expertise dedicated to facilitating and accelerating the delivery of image-driven ophthalmic innovations to the clinic.

Translational Imaging Innovations, Inc. (TII) was founded by Eric Buckland, Ph.D., co-founder and CEO of OCT innovator Bioptigen. TII was formed directly as a response to opportunity and challenges of translational imaging in ophthalmology observed during his Bioptigen tenure.

Eric Buckland, PhD

CEO

Rob Williams, MBA

CTO

Micaela Mendlow, PhD

Computational scientist

Alex Salmon, PhD

DATA SCIENTIST

Eva Kielczewski

Software Quality and Applications

Joseph Carroll, PhD

Chief Science Advisor

Brad Fortner, PhD

DATA Science Advisor

Rob Cooper, PhD

Biomarker Scientist

Bhavna Antony

Ophthalmic AI Advisor

Ron Schuchard

Clinical Endpoints Advisor

Jim Golando

Clinical Trials Advisor

Ready to see how TII can change the way you conduct translational research?

Accelerate your programs and deliver benefits to patients, faster, at a lower cost, and with less frustration.

Image-Driven Ophthalmic Innovation

PRODUCTS

ABOUT

CONNECT